AG-181

DRUG2 trials

Sponsors

Agios Pharmaceuticals, Inc.

Conditions

Healthy VolunteersPhenylketonuria

Phase 1

Single and Multiple Ascending Dose Study and Food Effect Study for AG181

CompletedNCT06286033

Agios Pharmaceuticals, Inc.Healthy Volunteers

Start: 2024-02-20End: 2025-10-09Updated: 2025-12-23

A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With Phenylketonuria

RecruitingNCT07241234

Agios Pharmaceuticals, Inc.Phenylketonuria

Start: 2026-04-17End: 2028-01-17Target: 20Updated: 2026-08-27